From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired resistance.
To join the conversation, visit https://cancergrace.org/forum.
Video Language:
Logo
You are here
RET/MET/BRAF: initial treatment, acquired resistance, Q&A Joshua Sabari, MD Joshua Bauml, MD
Related Content
Video
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.
Dr. Jack West has a virtual discussion with Helena A. Yu, MD, medical oncologist with Memorial Sloan Kettering specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.
Video
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.
Dr. Jack West has a virtual discussion with Helena A. Yu, MD, Medical Oncologist with Memorial Sloan Kettering, specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.
Video
For this new addition to the GRACE Lung Cancer Video Library, Dr. Taofeek Owonikoko joins GRACE to discuss current updates in small cell lung cancer.
In this video, Dr. Owonikoko discusses updated information on treatment options for relapsed sclc.
To join the conversation, visit https://cancergrace.org/forum.